APRIL STONE: Open Payments
NPI 1306380613 · BARRINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,934 in 94 payments from 14 companies in 2025. Trend: 2023 $1,282 · 2024 $1,355 · 2025 $1,934
Food & beverage: $1,934
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 25 | $487 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $454 |
| ABBVIE INC. | 15 | $237 |
| Vanda Pharmaceuticals Inc. | 13 | $196 |
| Alkermes, Inc. | 4 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
| Otsuka America Pharmaceutical, Inc. | 6 | $96 |
| Lundbeck LLC | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Almatica Pharma LLC | 1 | $18 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, FANAPT, REXULTI, LYBALVI, TRINTELLIX, COBENFY.
Industry payments across NJ — which companies pay providers there.
